Treatment of hantavirus pulmonary syndrome

被引：91

作者：

Jonsson, Colleen B. ^{[1
]}

Hooper, Jay ^{[2
]}

Mertz, Gregory ^{[3
]}

机构：

[1] So Res Inst, Dept Biochem & Mol Biol, Birmingham, AL 35205 USA

[2] USA, Med Res Inst Infect Dis, Mol Virol Branch, Ft Detrick, MD 21702 USA

[3] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA

来源：

ANTIVIRAL RESEARCH | 2008年 / 78卷 / 01期

关键词：

hantavirus; HPS; HFRS; hantavirus pulmonary syndrome; bunyavirus; antiviral therapy; ribavirin;

D O I：

10.1016/j.antiviral.2007.10.012

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Viruses in the genus Hantavirus can cause one of two serious illnesses when transmitted from rodents to humans: hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). Of the two diseases, HPS is more severe with an approximate 40% mortality across the Americas. The high rate of mortality could be reduced if effective therapeutics could be discovered for treatment of this illness. Herein we review approaches being explored for the discovery of therapeutics for HPS and how they could be employed in treatment and preventiom of disease. (C) 2007 Elsevier B.V. All rights reserved.

引用

页码：162 / 169

页数：8

共 100 条

[61]

2-S

[62] Andes virus infection of cynomolgus macaques [J].

McElroy, AK ;

Bray, M ;

Reed, DS ;

Schmaljohn, CS .

JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (12) :1706-1712

[63] HANTAAN VIRUS-INFECTION IN SUCKLING MICE - VIROLOGIC AND PATHOLOGIC CORRELATES [J].

MCKEE, KT ;

KIM, GR ;

GREEN, DE ;

PETERS, CJ .

JOURNAL OF MEDICAL VIROLOGY, 1985, 17 (02) :107-117

[64] Ribavirin, human convalescent plasma and anti-β3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model [J].

Medina, Rafael A. ;

Mirowsky-Garcia, Katy ;

Hutt, Julie ;

Hjelle, Brian .

JOURNAL OF GENERAL VIROLOGY, 2007, 88 :493-505

[65] Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America [J].

Mertz, GJ ;

Miedzinski, L ;

Goade, D ;

Pavia, AT ;

Hjelle, B ;

Hansbarger, CO ;

Levy, H ;

Koster, FT ;

Baum, K ;

Lindemulder, A ;

Wang, W ;

Riser, L ;

Fernandez, H ;

Whitley, RJ .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) :1307-1313

[66] Diagnosis and treatment of new world hantavirus infections [J].

Mertz, Gregory J. ;

Hjelle, Brian ;

Crowley, Mark ;

Iwamoto, Gary ;

Tomicic, Vinko ;

Vial, Pablo A. .

CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (05) :437-442

[67] Maporal viral infection in the Syrian golden hamster: A model of hantavirus pulmonary syndrome [J].

Milazzo, ML ;

Eyzaguirre, EJ ;

Molina, CP ;

Fulhorst, CF .

JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10) :1390-1395

[68]

Moolenaar R L, 1997, Semin Respir Infect, V12, P31

[69] CLINICAL-FEATURES THAT DIFFERENTIATE HANTAVIRUS PULMONARY SYNDROME FROM 3 OTHER ACUTE RESPIRATORY ILLNESSES [J].

MOOLENAAR, RL ;

DALTON, C ;

LIPMAN, HB ;

UMLAND, ET ;

GALLAHER, M ;

DUCHIN, JS ;

CHAPMAN, L ;

ZAKI, SR ;

KSIAZEK, TG ;

ROLLIN, PE ;

NICHOL, S ;

CHEEK, JE ;

BUTLER, JC ;

PETERS, CJ ;

BREIMAN, RF .

CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :643-649

[70] Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses [J].

Nicacio, CD ;

Della Valle, MG ;

Padula, P ;

Björling, E ;

Plyusnin, A ;

Lundkvist, Å .

JOURNAL OF VIROLOGY, 2002, 76 (13) :6669-6677

← 1 2 3 4 5 6 7 8 9 10 →